Cargando…
Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19
CD4(+) T cells reactive against SARS-CoV-2 can be found in unexposed individuals, and these are suggested to arise in response to common cold coronavirus (CCCoV) infection. Here, we utilized SARS-CoV-2-reactive CD4(+) T cell enrichment to examine the antigen avidity and clonality of these cells, as...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689350/ https://www.ncbi.nlm.nih.gov/pubmed/33296686 http://dx.doi.org/10.1016/j.immuni.2020.11.016 |
_version_ | 1783613848075370496 |
---|---|
author | Bacher, Petra Rosati, Elisa Esser, Daniela Martini, Gabriela Rios Saggau, Carina Schiminsky, Esther Dargvainiene, Justina Schröder, Ina Wieters, Imke Khodamoradi, Yascha Eberhardt, Fabian Vehreschild, Maria J.G.T. Neb, Holger Sonntagbauer, Michael Conrad, Claudio Tran, Florian Rosenstiel, Philip Markewitz, Robert Wandinger, Klaus-Peter Augustin, Max Rybniker, Jan Kochanek, Matthias Leypoldt, Frank Cornely, Oliver A. Koehler, Philipp Franke, Andre Scheffold, Alexander |
author_facet | Bacher, Petra Rosati, Elisa Esser, Daniela Martini, Gabriela Rios Saggau, Carina Schiminsky, Esther Dargvainiene, Justina Schröder, Ina Wieters, Imke Khodamoradi, Yascha Eberhardt, Fabian Vehreschild, Maria J.G.T. Neb, Holger Sonntagbauer, Michael Conrad, Claudio Tran, Florian Rosenstiel, Philip Markewitz, Robert Wandinger, Klaus-Peter Augustin, Max Rybniker, Jan Kochanek, Matthias Leypoldt, Frank Cornely, Oliver A. Koehler, Philipp Franke, Andre Scheffold, Alexander |
author_sort | Bacher, Petra |
collection | PubMed |
description | CD4(+) T cells reactive against SARS-CoV-2 can be found in unexposed individuals, and these are suggested to arise in response to common cold coronavirus (CCCoV) infection. Here, we utilized SARS-CoV-2-reactive CD4(+) T cell enrichment to examine the antigen avidity and clonality of these cells, as well as the relative contribution of CCCoV cross-reactivity. SARS-CoV-2-reactive CD4(+) memory T cells were present in virtually all unexposed individuals examined, displaying low functional avidity and multiple, highly variable cross-reactivities that were not restricted to CCCoVs. SARS-CoV-2-reactive CD4(+) T cells from COVID-19 patients lacked cross-reactivity to CCCoVs, irrespective of strong memory T cell responses against CCCoV in all donors analyzed. In severe but not mild COVID-19, SARS-CoV-2-specific T cells displayed low functional avidity and clonality, despite increased frequencies. Our findings identify low-avidity CD4(+) T cell responses as a hallmark of severe COVID-19 and argue against a protective role for CCCoV-reactive T cells in SARS-CoV-2 infection. |
format | Online Article Text |
id | pubmed-7689350 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76893502020-11-27 Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19 Bacher, Petra Rosati, Elisa Esser, Daniela Martini, Gabriela Rios Saggau, Carina Schiminsky, Esther Dargvainiene, Justina Schröder, Ina Wieters, Imke Khodamoradi, Yascha Eberhardt, Fabian Vehreschild, Maria J.G.T. Neb, Holger Sonntagbauer, Michael Conrad, Claudio Tran, Florian Rosenstiel, Philip Markewitz, Robert Wandinger, Klaus-Peter Augustin, Max Rybniker, Jan Kochanek, Matthias Leypoldt, Frank Cornely, Oliver A. Koehler, Philipp Franke, Andre Scheffold, Alexander Immunity Article CD4(+) T cells reactive against SARS-CoV-2 can be found in unexposed individuals, and these are suggested to arise in response to common cold coronavirus (CCCoV) infection. Here, we utilized SARS-CoV-2-reactive CD4(+) T cell enrichment to examine the antigen avidity and clonality of these cells, as well as the relative contribution of CCCoV cross-reactivity. SARS-CoV-2-reactive CD4(+) memory T cells were present in virtually all unexposed individuals examined, displaying low functional avidity and multiple, highly variable cross-reactivities that were not restricted to CCCoVs. SARS-CoV-2-reactive CD4(+) T cells from COVID-19 patients lacked cross-reactivity to CCCoVs, irrespective of strong memory T cell responses against CCCoV in all donors analyzed. In severe but not mild COVID-19, SARS-CoV-2-specific T cells displayed low functional avidity and clonality, despite increased frequencies. Our findings identify low-avidity CD4(+) T cell responses as a hallmark of severe COVID-19 and argue against a protective role for CCCoV-reactive T cells in SARS-CoV-2 infection. Elsevier Inc. 2020-12-15 2020-11-26 /pmc/articles/PMC7689350/ /pubmed/33296686 http://dx.doi.org/10.1016/j.immuni.2020.11.016 Text en © 2020 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Bacher, Petra Rosati, Elisa Esser, Daniela Martini, Gabriela Rios Saggau, Carina Schiminsky, Esther Dargvainiene, Justina Schröder, Ina Wieters, Imke Khodamoradi, Yascha Eberhardt, Fabian Vehreschild, Maria J.G.T. Neb, Holger Sonntagbauer, Michael Conrad, Claudio Tran, Florian Rosenstiel, Philip Markewitz, Robert Wandinger, Klaus-Peter Augustin, Max Rybniker, Jan Kochanek, Matthias Leypoldt, Frank Cornely, Oliver A. Koehler, Philipp Franke, Andre Scheffold, Alexander Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19 |
title | Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19 |
title_full | Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19 |
title_fullStr | Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19 |
title_full_unstemmed | Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19 |
title_short | Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19 |
title_sort | low-avidity cd4(+) t cell responses to sars-cov-2 in unexposed individuals and humans with severe covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689350/ https://www.ncbi.nlm.nih.gov/pubmed/33296686 http://dx.doi.org/10.1016/j.immuni.2020.11.016 |
work_keys_str_mv | AT bacherpetra lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT rosatielisa lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT esserdaniela lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT martinigabrielarios lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT saggaucarina lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT schiminskyesther lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT dargvainienejustina lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT schroderina lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT wietersimke lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT khodamoradiyascha lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT eberhardtfabian lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT vehreschildmariajgt lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT nebholger lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT sonntagbauermichael lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT conradclaudio lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT tranflorian lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT rosenstielphilip lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT markewitzrobert lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT wandingerklauspeter lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT augustinmax lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT rybnikerjan lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT kochanekmatthias lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT leypoldtfrank lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT cornelyolivera lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT koehlerphilipp lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT frankeandre lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 AT scheffoldalexander lowaviditycd4tcellresponsestosarscov2inunexposedindividualsandhumanswithseverecovid19 |